Dividend Opportunity: The article highlights a unique investment opportunity in the UK insurer Phoenix Group, which is pulling GBP22 billion from Aberdeen Group to manage funds in-house, presenting a 12%+ dividend yield in a struggling sector.
Aberdeen's Performance Issues: Aberdeen Group has faced poor performance and negative sentiment, particularly with its international closed-end funds, leading to a focus on two specific funds, abrdn Healthcare Investors (HQH) and abrdn Healthcare Opportunities Fund (THQ), which have shown better performance against benchmarks.
Investment Potential: HQH is noted for its deeper discount and better-performing portfolio compared to THQ, making it an attractive option for investors seeking dividends and potential capital gains as market sentiment around pharmaceuticals may improve.
Monthly Payout Preference: The author expresses a preference for funds that offer monthly payouts, which indicate management confidence, and suggests considering five top monthly dividend closed-end funds with a yield of 10.2% and potential for 20% capital gains.
Wall Street analysts forecast THQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
Wall Street analysts forecast THQ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THQ is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
0 Sell
Current: 19.790
Low
Averages
High
Current: 19.790
Low
Averages
High
No data
About THQ
abrdn Healthcare Opportunities Fund (the Fund), formerly Tekla Healthcare Opportunities Fund, is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. The Fund invests up to 20 % of managed assets, measured at the time of investment, in the debt of healthcare companies. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. It invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
